Tools for assessing psoriatic arthritis domains, advantages and disad-vantages
Abstract
The relevance of the problem of adequate assessment of the activity of psoriasis and psoriatic arthritis is beyond doubt.
The aim of the study is to analyze the advantages and disadvantages of existing scales of psoriasis and psoriatic arthritis severity. The diversity of clinical manifestations of psoriatic disease determines the presence of many indices. Clinical guidelines for practicing physicians present indices for individual clinical domains or complex ones combining several indicators.
Results and conclusions. The disparity of practical tools dictates the search for a universal index for dermatologists and rheumatologists in determining the tactics of managing patients with psoriatic disease.
About the Authors
I. V. Devald
South-Urals State Medical University;
Chelyabinsk State University
Russian Federation
Russian Federation
Chelyabinsk
K. Y. Myslivtsova
South-Urals State Medical University
Russian Federation
Russian Federation
Chelyabinsk
E. A. Bogdanova
South-Urals State Medical University
Russian Federation
Russian Federation
Chelyabinsk
E. A. Khodus
Chelyabinsk State University
Russian Federation
Russian Federation
Chelyabinsk
G. L. Ignatova
South-Urals State Medical University
Russian Federation
Russian Federation
Chelyabinsk
References
1. Российские клинические рекомендации. Ревматология. – 22.06.2024. – URL: https://www.rosmedlib.ru/book/ ISBN9785970442616.html
2. Karmacharya, P. The epidemiology of psoriatic arthritis: A literature review / Р. Karmacharya, R. Chakradhar, A. Ogdie // Best Pract Res Clin Rheumatol. 2021. Т35. № 2. С.101-692.
3. Gupta, S. Comorbidities in psoriatic arthritis: a systematic review and meta-analysis / S. Gupta, Z. Syrimi, D.M. Hughes, S.S. Zhao // Rheumatol Int. 2021. Т.41. № 2. С. 275–84.
4. Рубрикатор КР. 2024. URL: https://cr.minzdrav.gov.ru/schema/234_2
5. Приложение «Рубрикатор КР». – 12.08.2024. – URL: https://minzdrav.gov.ru/smartphone_apps_rubrikator_kr
6. Schmitt, J. The psoriasis area and severity index is the adequate criterion to defi severity in chronic plaque-type psoriasis /J. Schmitt, G. Wozel // Dermatology. 2005. Т.210. № 3. С.194–9.
7. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use – 22.06.2024. – URL: https://pubmed.ncbi.nlm.nih.gov/8033378/
8. Schoels, M.M. Disease activity in psoriatic arthritis (PsA): defi remission and treatment success using the DAPSA score / M.M Schoels, D. Aletaha, F. Alasti, J.S. Smolen // Ann Rheum Dis. 2016. Т.75. № 5. С.811–8.
9. Mease, P.J. Performance of 3 Enthesitis Indices in Patients with Peripheral Spondyloarthritis During Treatment with Adalimumab / P.J. Mease, F. Van den Bosch, J. Sieper, Y. Xia, A.L. Pangan, I.H. Song // J Rheumatol. 2017. Т.44. № 5. С.599–608.
10. Егудина, Е.Д. Энтезит – ключ к диагнозу спондилоартрита, акцент на псориатический артрит / Е.Д. Егудина, С.А. Триполка // Современная ревматология. 2021. Т.15. № 1. С.79–86.
11. Garrett, S. A new approach to defi disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index / S. Garrett, Т. Jenkinson, L.G. Kennedy, Н. Whitelock, Р. Gaisford, А. Calin // J Rheumatol. 1994. Т.21. № 12. С.2286–91.
12. Дубинина, Т.В. Рекомендации по оценке активности болезни и функционального состояния больных анкилозирующим спондилитом в клинической практике / Т.В, Дубинина, И.З. Гайдукова, А.А.Годзенко, и др. // Научно-практическая ревматология. 2017. Т.55. № 4. С.344-350.
13. Koreshkova, K.M. Quality of life in psoriatic arthritis: review of selected assessment methods and their results / К.М. Koreshkova, Z.R. Khismatullina // Klin dermatol venerol. 2022. Т.21. № 1. С. 15-18.
14. Губарь, Е.Е. Поражение ногтей при псориатическом артрите. Данные общероссийского регистра / Е.Е. Губарь, Ю.Л. Корсакова, Е.Ю. Логинова,Т.В, и др. // Научно-практическая ревматология. -2021. Т.59. № 5. С.563–70.
15. Александрович, О.Ю. Оценка активности заболевания при ревматоидном артрите: рекомендации и практика / О.Ю. Александрович // Современная ревматология. -2014. Т.2. № 4. С.4–9.
16. Coates, L.C. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 / L.C. Coates, E.R.Soriano, N. Corp, et al. // Nat Rev Rheumatol. 2022. Т.18. №8. С.465–79.
17. Rich, P. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis / Р. Rich, R.K. Scher //J Am Acad Dermatol. 2003. Т.49. №2. С.206–12.
18. Платонова, А.В. Псориатическая ониходистрофия: индексы оценки степени тяжести (часть 2) / А.В. Платонова, А.С. Жуков, В.Р. Хайрутдинов, А.В. Самцов // Вестник дерматологии и венерологии. 2019. Т. 95. №1. C. 9-14. doi: 10.25208/00424609-2019-95-1-9-14
19. Helliwell, P.S. Development of an assessment tool for dactylitis in patients with psoriatic arthritis / P.S. Helliwell, J. Firth, G.H. Ibrahim, et al. // J Rheumatol. 2005. Т. 32. №9. C.745-50. PMID: 16142872.
20. Healy, P.J. Measuring dactylitis in clinical trials: which is the best instrument to use? / P.J. Healy, P.S. Helliwell // J Rheumatol. 2007. Т. 34. №6. C.1302-1306.
21. Orbai, A.M. Patient-Reported Outcomes in Psoriatic Arthritis / А.М, Orbai, А. Ogdie // Rheum Dis Clin North Am. 2016. Т. 42. №2. C.265–83.
22. Strand, V. Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and eff of etanercept treatment / V. Strand, V. Sharp, A.S. Koenig,G. Park, Y. Shi, В.Wang, et al. // Annals of the Rheumatic Diseases. 2012. Т. 71. №7. C.1143–50.
23. Leung, Y.Y. OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF / Y.Y. Leung, A.M. Orbai, Р. Hojgaard, R. Holland, A.J. Mathew, N.Goel, et al. // Semin Arthritis Rheum. 2021. Т. 51. №5. C.1117–24.
24. Leung, Y.Y. Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group / Y.Y. Leung, A.M. Orbai, W. Tillett, et al. // J Rheumatol Suppl. 2021. Т. 97. C.60-63. doi:10.3899/jrheum.201679
25. Ware, J.E. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection / J.E. Ware, C.D. Sherbourne // Med Care. 1992. Т. 30. №6. C.473–83.
26. Husted, J.A. Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis / J.A. Husted, D.D. Gladman, V.T. Farewell, J.A. Long, R.J. Cook // J Rheumatol.1997. Т. 24. №3. C.511–7.
27. Воробьева, Л.Д. Валидация русскоязычной версии опросника PsAID-12 у пациентов с псориатическим артритом / Л.Д.Воробьева, Е.Ю. Логинова, Ю.Л. Корсакова, Е.Е. Губарь, П.О. Тремаскина, Т.В. Коротаева // Научно-практическая ревматология. 2022. Т. 60. №2. C.188–94.
28. Gossec, L. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update / L.Gossec, J.S. Smolen, S.Ramiro, M. de Wit, M. Cutolo, M. Dougados, et al. // Ann Rheum Dis. 2016. Т. 75. №3. C.499–510.
29. Coates, L.C. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis/ L.C. Coates, O. FitzGerald, J.F. Merola, J. Smolen, van Mens LJJ, H. Bertheussen, et al.// Arthritis Rheumatol. 2018. Т. 70. №3. C.345–55.
30. Корсакова, Ю.Л. Псориаз и псориатический артрит: актуальные вопросы / Ю.Л. Корсакова // Современная ревматология. 2012. Т. 6. №3. C.28–32.
31. Mumtaz, A. Development of a preliminary composite disease activity index in psoriatic arthritis / А. Mumtaz, Р. Gallagher, В. Kirby, R. Waxman, L.C. Coates, J.D.Veale et al.// Ann Rheum Dis. 2011. Т. 70. №2. C.272–7.
32. Helliwell, P.S. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) / P.S. Helliwell, О. FitzGerald, J. Fransen, D.D. Gladman, G.G. Kreuger, K. Callis-Duffi et al. // Ann Rheum Dis. 2013. Т. 72. №6. C.986–91.
33. Корсакова, Ю.Л. Новый интегральный энтезиально-коморбидный индекс оценки активности псориатического артрита/ Ю.Л.Корсакова, Т.В.Коротаева, Е.Ю.Логинова, Е.Е.Губарь, Л.Д.Воробьева, С.И.Глухова, Е.Л.Насонов // Терапевтический архив. 2023. Т. 95. №5. C.404–409. DOI: 10.26442/00403660.2023.05.202197
Review
For citations:
Devald I.V., Myslivtsova K.Y., Bogdanova E.A., Khodus E.A., Ignatova G.L. Tools for assessing psoriatic arthritis domains, advantages and disad-vantages. Title in english. 2024;19(3):21-24. (In Russ.)
Views:
34
Email this article 